MSB 0.54% 92.5¢ mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-265

  1. 7,922 Posts.
    lightbulb Created with Sketch. 627
    Again I feel as though nothing that has been said in the last few years has sunk in
    The Ryoncil phase 3 trial met it’s endpoints….so where do you link your theoretical failure of Mesoblast to Osiris to where we are now
    In fact I might opine that each trial has been a scientific journey of discovery and as a consequence the upcoming PDUFA date might usher a new form of medicine upon approval which is the complete opposite to what you just posted
    Last edited by stocksa: 28/05/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
92.5¢
Change
0.005(0.54%)
Mkt cap ! $1.056B
Open High Low Value Volume
93.0¢ 93.5¢ 91.5¢ $1.473M 1.596M

Buyers (Bids)

No. Vol. Price($)
1 32370 92.5¢
 

Sellers (Offers)

Price($) Vol. No.
93.0¢ 60258 5
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.